- Report
- February 2025
- 315 Pages
Global
From €4298EUR$4,799USD£3,664GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- March 2025
- 1048 Pages
Global
From €4298EUR$4,799USD£3,664GBP
- Report
- May 2025
- 194 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 386 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 419 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2687EUR$3,000USD£2,291GBP
- Report
- January 2025
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- March 2023
- 300 Pages
Global
From €2508EUR$2,800USD£2,138GBP
- Report
- July 2022
- 165 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2024
- 200 Pages
Global
From €7121EUR$7,950USD£6,070GBP
- Report
- November 2023
- 171 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- August 2024
- 84 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- February 2024
- 112 Pages
Global
From €3500EUR$4,186USD£3,088GBP

The TIL Therapies market within the context of Oncology Drugs is a rapidly growing field of research and development. TIL stands for Tumor Infiltrating Lymphocytes, which are a type of immune cell that can be used to fight cancer. TIL therapies involve extracting these cells from a patient's tumor, expanding them in the laboratory, and then re-injecting them back into the patient. This type of therapy has been shown to be effective in treating certain types of cancer, such as melanoma and ovarian cancer.
TIL therapies are still in the early stages of development, but they have the potential to revolutionize the way cancer is treated. The market for TIL therapies is expected to grow significantly in the coming years as more research is conducted and more clinical trials are conducted.
Some of the companies in the TIL Therapies market include Adaptimmune, Atara Biotherapeutics, Bellicum Pharmaceuticals, and Kite Pharma. Show Less Read more